A detailed history of Iht Wealth Management, LLC transactions in Geron Corp stock. As of the latest transaction made, Iht Wealth Management, LLC holds 29,350 shares of GERN stock, worth $124,444. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,350
Previous 31,350 6.38%
Holding current value
$124,444
Previous $66,000 45.45%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.75 - $3.44 $3,500 - $6,880
-2,000 Reduced 6.38%
29,350 $96,000
Q4 2023

Feb 14, 2024

SELL
$1.74 - $2.31 $5,220 - $6,930
-3,000 Reduced 8.73%
31,350 $66,000
Q2 2023

Aug 14, 2023

SELL
$1.97 - $3.69 $8,865 - $16,605
-4,500 Reduced 11.58%
34,350 $110,000
Q1 2023

May 15, 2023

BUY
$2.14 - $3.4 $21,400 - $34,000
10,000 Added 34.66%
38,850 $84,000
Q4 2022

Feb 14, 2023

SELL
$2.03 - $2.42 $2,029 - $2,420
-1,000 Reduced 3.35%
28,850 $69,000
Q2 2021

Aug 16, 2021

SELL
$1.25 - $1.83 $1,250 - $1,830
-1,000 Reduced 3.24%
29,850 $42,000
Q3 2020

Nov 19, 2020

BUY
$1.59 - $2.19 $1,590 - $2,190
1,000 Added 3.35%
30,850 $54,000
Q2 2020

Aug 14, 2020

SELL
$1.05 - $2.18 $4,200 - $8,720
-4,000 Reduced 11.82%
29,850 $65,000
Q1 2020

May 13, 2020

SELL
$0.89 - $1.49 $1,780 - $2,980
-2,000 Reduced 5.58%
33,850 $40,000
Q3 2019

Nov 15, 2019

BUY
$1.15 - $1.59 $3,449 - $4,770
3,000 Added 9.13%
35,850 $48,000
Q2 2019

Aug 12, 2019

SELL
$1.37 - $2.02 $6,713 - $9,898
-4,900 Reduced 12.98%
32,850 $46,000
Q1 2019

May 16, 2019

BUY
$1.01 - $1.83 $1,010 - $1,830
1,000 Added 2.72%
37,750 $63,000
Q4 2018

Feb 15, 2019

BUY
$0.98 - $1.85 $36,015 - $67,987
36,750 New
36,750 $37,000
Q2 2018

Aug 13, 2018

SELL
$3.29 - $4.82 $16,450 - $24,100
-5,000 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$1.8 - $2.32 $4,500 - $5,800
2,500 Added 100.0%
5,000 $9,000
Q3 2017

Nov 14, 2017

BUY
$1.99 - $2.65 $4,975 - $6,625
2,500
2,500 $6,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.6B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Iht Wealth Management, LLC Portfolio

Follow Iht Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iht Wealth Management, LLC with notifications on news.